Navigation Links
MEDRAD Sponsors PET Research with University of Zurich
Date:1/6/2009

This enables the clinician to easily and efficiently respond to schedule changes, patient delays, and add-on patients. Innovative features, including real-time dose availability information, an integrated ionization chamber, and an optional weight-based dose calculation, allow the healthcare provider to more precisely customize each patient's dose. Safety features include a tungsten multi-dose vial shield, a fully lead-lined mobile cart, and an automated saline flush to remove residual FDG from the line after each infusion.

"Supporting this research with the University of Zurich is an exciting opportunity for us. We believe the Intego System can be a very important tool for advancing PET imaging in the clinical setting, leading to better patient management and clinical outcomes," said Doug Descalzi, Executive Director, MEDRAD Molecular Imaging.

About University of Zurich

The University of Zurich was founded in 1833, though its origins stretch back as far as 1525. Today the University enjoys international renown as a place of education and research. Two thousand lecturers in 140 special institutes provide the broadest range of subjects and courses available from any Swiss seat of higher education. With 24,000 students and 1,900 graduates every year, Zurich is also Switzerland's largest university. The University provides academic services, works with the private sector and considers itself part of a national and global network for the acquisition and dissemination of knowledge. The University of Zurich is member of the League of European Research Universities (LERU), an association of the twenty leading European universities sharing the values of high-quality teaching within an environment of internationally competitive research.

About MEDRAD

MEDRAD, Inc., is a worldwide leading provider of medical devices and services that enable and enhance imaging and therapeu
'/>"/>

SOURCE MEDRAD, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. MEDRAD Builds on Success of P3T Cardiac CT Injection Software
2. MEDRAD Multi Vendor Service Forms Alliance with Wetsco
3. MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System
4. MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery
5. MEDRAD(R) Revenues Grow 10 Percent in 2007
6. MEDRAD Mobile MR Injector Meets Challenges of MR Trailers
7. MEDRAD Plant Named IndustryWeek Magazine Award Finalist
8. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
9. My Bank Tracker Sponsors "Keep A Child Alive"
10. Green Family Foundation Sponsors Alicia Keys Keep a Child Alive College Student AIDS Summit
11. Alcohol sponsorship linked to hazardous drinking in sportspeople
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... September 30, 2014 For Dr. Jim Pertsch, ... in San Mateo, CA, the decision was simple. “I was ... when I heard Miele offered a solution for cleaning surgical ... for ways to help the staff, and the Miele system ... and I don’t worry as much about the staff coming ...
(Date:9/30/2014)... CE-Classes.com has announced the addition of ... for Healthcare Providers. This course on treating tobacco addiction ... - substance abuse counselors, social workers, professional counselors, psychologists, ... implementation of this new course” said Ron Black, president ... smoking has tremendous value to our society.” , Appropriate ...
(Date:9/29/2014)... September 30, 2014 Shoulder pain is one ... with persistent shoulder pain generates nearly ¾ of the total ... of all adults will experience shoulder pain, and of those ... also been reported that 1 in 4 people with either ... than a year. , “This is a real problem, not ...
(Date:9/29/2014)... 30, 2014 Foundations Recovery Network, an ... the start of its 40th national conference by hosting ... a featured keynote speaker at the Moments of Change ... in the fields of addiction and mental health treatment. ... Fla., September 29 – October 2, 2014, at The ...
(Date:9/29/2014)... Boston, MA A retrospective study led by ... found an overuse of colonoscopies for colorectal cancer ... commonly recommended shorter follow-up intervals than established guidelines ... subsequent colonoscopy overuse. , "Our study shows ... being performed too early, resulting in use of ...
Breaking Medicine News(10 mins):Health News:Introducing a Safe, Time-Saving Solution for Ambulatory Surgery Centers 2Health News:Introducing a Safe, Time-Saving Solution for Ambulatory Surgery Centers 3Health News:CE-Classes.com Introduces New Online Course for Healthcare Providers 2Health News:CE-Classes.com Introduces New Online Course for Healthcare Providers 3Health News:KORT Physical Therapist Shines a Light on Shoulder Pain and Latest Treatments 2Health News:Glenn Greenwald Addresses Drug Decriminalization at Foundations Recovery Network’s 40th National Conference 2Health News:Glenn Greenwald Addresses Drug Decriminalization at Foundations Recovery Network’s 40th National Conference 3Health News:Endoscopists recommend frequent colonoscopies, leading to its overuse 2
... , , WASHINGTON, July 9 The ... the work of the National Organization on Disability,s (N.O.D.) ... emergency managers and the disability community as the only ... and personnel experienced in emergency management and disability issues. ...
... 9 The ongoing recession and associated job cuts ... employee benefit plans, slowing health insurer growth and pressuring ... and Consulting. , , "Conning projects that health ... resulting in deteriorating margins through 2011," said Terence Martin, ...
... Hospital for Special Surgery have shown that a biodegradable scaffold ... knee cartilage. The study is unique in that it used ... to examine how the plug incorporated itself into the knee. ... meeting of the American Orthopedic Society for Sports Medicine, June ...
... ... the world,s leading manufacturer and distributor of automated blood pressure monitors and health testing ... ... 2009 -- Lifeclinic International has named Lon von Hurwitz Executive Vice President ...
... externally , THURSDAY, July 9 (HealthDay News) -- U.S. ... ear infections in children. , Antibiotics are typically used ... for children with recurrent ear infections. , "The emergence ... surgical procedure raise the need to develop different ways ...
... 9 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International Limited (NYSE: ... devices worldwide, today announced that it will report its,financial ... after the U.S.,market closes on August 10, 2009. Mindray,s ... on August 11, 2009 U.S. Eastern Time (8:00 PM ...
Cached Medicine News:Health News:Walmart Foundation Commits $500,000 to Improving Emergency Preparedness for the 54 Million Americans with Disabilities 2Health News:Walmart Foundation Commits $500,000 to Improving Emergency Preparedness for the 54 Million Americans with Disabilities 3Health News:Conning Research: Health Insurance Industry Premium Growth and Profitability Under Pressure Through 2011 2Health News:Study identifies potential fix for damaged knees 2Health News:Study identifies potential fix for damaged knees 3Health News:Pioneer of Digital Place-Based Media Joins World's Leading Blood Pressure and Health Kiosk Manufacturer 2Health News:Vaccine May Someday Thwart Ear Infections 2Health News:Mindray to Report Second Quarter 2009 Financial Results on August 10, 2009 2
(Date:9/29/2014)...  Volcano Corporation (Nasdaq: VOLC ), ... economic outcomes on a global basis by developing ... visualization, physiology diagnostics and therapies, today confirmed receipt ... from Engaged Capital, LLC.  The Company issued the ... welcomes the perspectives of its shareholders, and has ...
(Date:9/29/2014)... YORK , Sept. 29, 2014 ... Summary GlobalData,s new report, "EU5 Esophagoscopes ... market data on the EU5 Esophagoscopes & Gastroscopes ... US dollars, volume (in units) and average prices ... Video Esophagoscopes, Flexible Non-Video (Fibre) Gastroscopes and Flexible ...
(Date:9/29/2014)... 29, 2014  Cancer Treatment Institute of ... new drug treatment: a carefully formulated, first-of-its-kind combination ... proven successful at treating multiple types of cancer. ... treatment are optimistic that it could significantly improve ... therapeutic avenues. "These two drugs are ...
Breaking Medicine Technology:Volcano Issues Statement Regarding Letter From Engaged Capital 2Volcano Issues Statement Regarding Letter From Engaged Capital 3EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 3Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 2Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 3
... GPRO ) announced today that the Company ... investigational APTIMA(R) assay to detect human,papillomavirus (HPV), which ... multi-center study was an important goal,for Gen-Probe in ... and,chief operating officer. "Enrolling our first patient last ...
... Alone and in combination with, Ramipril Global Endpoint ... Annual Scientific Session of the American College of ... online in the New England Journal of Medicine, ... the landmark,ONTARGET(TM) trial have demonstrated that MICARDIS(R) (telmisartan), ...
Cached Medicine Technology:Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 2Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 3Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 4Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 5Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population 2Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population 3Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population 4Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population 5Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population 6Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population 7
Curved shaft with flat 4.5 mm hook. Flat serrated handle with polished finish. Overall length: 5.3 inches....
... device allows for quick and ... ophthalmic surgical procedures. The "Quick ... through which a suture may ... during the loading procedure. The ...
Titanium. Small "H" shaped push-pull tip. Shaft angled 45 degrees, 9 mm from tip. Round knurled handle with dull finish. Overall length: 4.8 inches. Most popular size or model....
Left angled 5 mm blunt hook. Overall length: 9.9 inches....
Medicine Products: